Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Cav2.2 blockers(Voltage-gated N-type calcium channel alpha-1B subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Neuropathies | Phase 2 | - | - | |
Diabetic Neuropathies | Phase 2 | - | - | |
Neuralgia, Postherpetic | Phase 2 | - | - | |
Neuralgia, Postherpetic | Phase 2 | - | - | |
Diabetic peripheral neuropathy | Phase 1 | HU | 01 Aug 2013 | |
Neuralgia | Phase 1 | HU | 01 Aug 2013 | |
Pain | Phase 1 | GB | - |